Screening of patients with tuberculosis for diabetes mellitus in China

Tropical Medicine and International Health

Volumn 17, Issue 10, 2012, Pages 1294-1301

  Li, Liang ^a   Lin, Yan ^b   Mi, Fengling ^a   Tan, Shouyong ^c   Liang, Bing ^c   Guo, Chaojun ^d   Shi, Lian ^e   Liu, Li ^f   Gong, Fang ^c   Li, Yuanyuan ^d   Chi, Jingyu ^g   Zachariah, Rony ^h   Kapur, Anil ⁱ   Lönnroth, Knut ^j   Harries, Anthony D ^k,l  

^a Clinical Center on Tuberculosis   (China)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c GUANGZHOU CHEST HOSPITAL   (China)

^d Xinjiang Chest Hospital   (China)

^e Shenyang Chest Hospital   (China)

^f Anding District CDC   (China)

^g SHANDONG PROVINCIAL CHEST HOSPITAL   (China)

^h MÉDECINS SANS FRONTIÈRES   (Belgium)

ⁱ World Diabetes Foundation   (Denmark)

^j WORLD HEALTH ORGANIZATION   (Switzerland)

^k INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^l LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

more..

Author keywords

China; Diabetes mellitus; Screening; Tuberculosis

Indexed keywords

GLUCOSE;

BLOOD; DIABETES; DISEASE PREVALENCE; GLUCOSE; HEALTH STATUS; PUBLIC HEALTH; RURAL POPULATION; SPATIOTEMPORAL ANALYSIS; STAKEHOLDER; TUBERCULOSIS;

ARTICLE; CHINA; DIABETES MELLITUS; FEASIBILITY STUDY; GLUCOSE BLOOD LEVEL; HEALTH CARE FACILITY; HOSPITAL PATIENT; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; PREVALENCE; RURAL AREA; SCREENING; URBAN AREA;

CHINA; CHINE; CRIBADO; DÉPISTAGE; DIABÈTE SUCRÉ; DIABETES MELLITUS; SCREENING; TUBERCULOSE; TUBERCULOSIS;

ADOLESCENT; ADULT; AMBULATORY CARE; BLOOD GLUCOSE; CHINA; DIABETES COMPLICATIONS; DIABETES MELLITUS; HOSPITALIZATION; HUMANS; INCIDENCE; MASS SCREENING; PILOT PROJECTS; PREVALENCE; QUESTIONNAIRES; RURAL POPULATION; TUBERCULOSIS; URBAN POPULATION;

CHINA;

EID: 84866365770     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2012.03068.x     Document Type: Article

References (27)

1. Alcorn T & Ouyang Y (2012) Diabetes saps health and wealth from China's rise. Lancet 379, 2227-2228.
2. Baker MA, Harries AD, Jeon CY et al. (2011) The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Medicine 9, 81.
3. Danaei G, Finucane MM, Lu Y et al. (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378, 31-40.
4. Dooley KE & Chaisson RE (2009) Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infectious Diseases 9, 737-746.
5. Goyal BN, Nigam P, Dubey AL, Joshi LD & Saxena HN (1978) Study of the diabetic status in pulmonary tuberculosis. Journal of Diabetes Association in India 18, 191-197.
6. Harries AD, Lin Y, Satyanarayana S et al. (2011) The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis. International Journal of Tuberculosis and Lung Disease 15, 1436-1444.
7. Howard AA & El-Sadr WM (2010) Integration of tuberculosis and HIV services in sub-Saharan Africa: lessons learned. Clinical Infectious Diseases 50, S238-S244.
8. International Diabetes Federation (2011) IDF Diabetes Atlas, 5th edn. International Diabetes Federation, Brussels. Available at: http://www.eatlas.idf.org (accessed 20 July 2011).
9. International Expert Committee (2009) International Expert Committee Report on the Role of the A1c Assay in the Diagnosis of Diabetes. Diabetes Care 32, 1327-1334.
10. Jeon CY & Murray MB (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Medicine 5, e152.
11. Jeon CY, Harries AD, Baker MA et al. (2010) Bi-directional screening for tuberculosis and diabetes: a systematic review. Tropical Medicine and International Health 15, 1300-1314.
12. Kishore B, Nagrath SP, Mathur KS, Hazra DK & Agarwal BD (1973) Manifest, chemical and latent chemical diabetes in pulmonary tuberculosis. Journal of the Association of Physicians of India 21, 875-881.
13. Kumar PR, Bhansali A, Ravikiran M et al. (2010) Utility of glycated hemoglobin in diagnosing type 2 diabetes mellitus: a community-based study. Journal of Clinical Endocrinology and Metabolism 95, 2832-2835.
14. Lawn SD & Wood R (2012) Timing of antiretroviral therapy for HIV-1-associated tuberculosis. New England Journal of Medicine 366, 474.
15. Lee M, Saver JL, Hong KS, Song S, Chang KH & Ovbiagele B (2012) Effect of pre-diabetes on future risk of stroke: meta-analysis. British Medical Journal 344, e3564.
16. Ministry of Health and Chinese Centre on TB Control and Prevention (CDC) (2008) National Tuberculosis Control Programme Guidelines. Peking Union Medical College Publishing House, Beijing, China.
17. Oluboyo PO & Erasmus RT (1990) The significance of glucose intolerance in pulmonary tuberculosis. Tubercle 71, 135-138.
18. Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF & Kahn SE, for the Diabetes Prevention Program Research Group (2012) Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet 379, 2243-2251.
19. Ruslami R, Aarnoutse RE, Alisjahbana B, van der Ven AJAM & van Crevel R (2010) Implications of the global increase of diabetes for tuberculosis control and patient care. Tropical Medicine and International Health 15, 1289-1299.
20. Singh MM, Biswas SK & Shah A (1984) Impaired glucose tolerance in active pulmonary tuberculosis. Indian Journal of Tuberculosis 31, 118-121.
21. Stevenson CR, Critchley JA, Forouhi NG et al. (2007) Diabetes and the risk of tuberculosis: a neglected threat to public health. Chronic Illness 3, 228-245.
22. World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Summary of Technical Report and Recommendations. World Health Organization, Geneva, Switzerland.
23. World Health Organization (2009) Treatment of Tuberculosis Guidelines, 4th edn. WHO, Geneva, Switzerland. WHO/HTM/TB/2009.420.
24. World Health Organization (2011a) WHO Report. Global Tuberculosis Control 2011. WHO/HTM/TB/2011.16. World Health Organization, Geneva, Switzerland.
25. World Health Organization (2011b). Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus: abbreviated report of a WHO consultation. WHO, Geneva, Switzerland. Available: http://www.who.int/cardiovascular_diseases/report-hba1c_2011_edited.pdf (accessed 14 September 2011).
26. World Health Organization and The International Union Against Tuberculosis and Lung Disease (2011) Provisional Collaborative Framework for care and control of Tuberculosis and Diabetes. World Health Organization and The International Union Against Tuberculosis and Lung Disease, Geneva, Switzerland.
27. Yang W, Lu J, Weng J et al. (2010) Prevalence of diabetes among men and women in China. New England Journal of Medicine 362, 1090-1101.